The What, Why and How of Bayesian Clinical Trials Monitoring. Freedman, L. S., Spiegelhalter, D. J., & Parmar, M. K. B. Stat Med, 13:1371-1383, 1994. bibtex @article{fre94wha,
title = {The What, Why and How of {{Bayesian}} Clinical Trials Monitoring},
volume = {13},
journal = {Stat Med},
author = {Freedman, Laurence S. and Spiegelhalter, David J. and Parmar, Mahesh K. B.},
year = {1994},
keywords = {bayesian-inference,study-design,sequential-monitoring,early-termination},
pages = {1371-1383},
citeulike-article-id = {13264101},
posted-at = {2014-07-14 14:09:29},
priority = {0},
annote = {gives example adjustment for sequential testing yields 0.95 CI that includes 0.0 even for data indicating that study should be stopped at the first interim analysis}
}
Downloads: 0
{"_id":"mBHk7JAmZGF6i72QA","bibbaseid":"freedman-spiegelhalter-parmar-thewhatwhyandhowofbayesianclinicaltrialsmonitoring-1994","downloads":0,"creationDate":"2018-06-23T20:06:37.440Z","title":"The What, Why and How of Bayesian Clinical Trials Monitoring","author_short":["Freedman, L. S.","Spiegelhalter, D. J.","Parmar, M. K. B."],"year":1994,"bibtype":"article","biburl":"http://hbiostat.org/bib/harrelfe.bib","bibdata":{"bibtype":"article","type":"article","title":"The What, Why and How of Bayesian Clinical Trials Monitoring","volume":"13","journal":"Stat Med","author":[{"propositions":[],"lastnames":["Freedman"],"firstnames":["Laurence","S."],"suffixes":[]},{"propositions":[],"lastnames":["Spiegelhalter"],"firstnames":["David","J."],"suffixes":[]},{"propositions":[],"lastnames":["Parmar"],"firstnames":["Mahesh","K.","B."],"suffixes":[]}],"year":"1994","keywords":"bayesian-inference,study-design,sequential-monitoring,early-termination","pages":"1371-1383","citeulike-article-id":"13264101","posted-at":"2014-07-14 14:09:29","priority":"0","annote":"gives example adjustment for sequential testing yields 0.95 CI that includes 0.0 even for data indicating that study should be stopped at the first interim analysis","bibtex":"@article{fre94wha,\n title = {The What, Why and How of {{Bayesian}} Clinical Trials Monitoring},\n volume = {13},\n journal = {Stat Med},\n author = {Freedman, Laurence S. and Spiegelhalter, David J. and Parmar, Mahesh K. B.},\n year = {1994},\n keywords = {bayesian-inference,study-design,sequential-monitoring,early-termination},\n pages = {1371-1383},\n citeulike-article-id = {13264101},\n posted-at = {2014-07-14 14:09:29},\n priority = {0},\n annote = {gives example adjustment for sequential testing yields 0.95 CI that includes 0.0 even for data indicating that study should be stopped at the first interim analysis}\n}\n\n","author_short":["Freedman, L. S.","Spiegelhalter, D. J.","Parmar, M. K. B."],"key":"fre94wha","id":"fre94wha","bibbaseid":"freedman-spiegelhalter-parmar-thewhatwhyandhowofbayesianclinicaltrialsmonitoring-1994","role":"author","urls":{},"keyword":["bayesian-inference","study-design","sequential-monitoring","early-termination"],"downloads":0},"search_terms":["bayesian","clinical","trials","monitoring","freedman","spiegelhalter","parmar"],"keywords":["bayesian-inference","early-termination","sequential-monitoring","study-design","*import"],"authorIDs":[],"dataSources":["mEQakjn8ggpMsnGJi"]}